MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm
THE EXPRESSION OF INOS IN MOUSE EXPERIMENTAL MODEL POINTS TO INFLAMMATORY CONDITIONS ASSOCIATED WITH PARKINSON’S DISEASE

N. Djebli (Mostaganem, Algeria)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
The first tremor dominant Parkinson’s Disease treatment in Taiwan using MR-guided focused ultrasound

HC. Lai, WK. Tsai, WC. Chang (Changhua County, Taiwan)

Tremor  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
The frequency and impact of mutations in the GBA gene and APOε4 polymorphisms on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, R. Shahar, T. Gurevich, A. Orr-Urtreger, N. Giladi, N. Bregman (Tel Aviv, Israel)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders

M. Kurian, V. Leuzzi, K. Peall, R. Pons, R. Dale, E. de Grandis, S. Yilmaz, J. Cobben, R. Guerrini, E. Sheridan, P. Vieira, J. Uusimaa, P. Munot, F. Muntoni, M. Smith, S. Mohammed, E. Meyer, J. Ng, A. Papandreou, H. Baide, F. Danti, A. Macaya, J. Ortigoza, K. Gorman, B. Perez Duenas (Barcelona, Spain)

Classification of Movement Disorders  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
The impact of HIV on the severity and course of Parkinson’s disease: a clinical case

A. Kudrevatykh, E. Gracheva, I. Miliukhina (St. Petersburg, Russian Federation)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
The impact of medication and deep brain stimulation on visuo-motor coordination in Parkinson’s disease

J. Daneault, A. Sadikot, B. Carignan, M. Panisset, C. Duval (Newark, NJ, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
The impact of physical activity and exercise on people living with dystonia

L. Bradnam, R. Meiring, A. Mccambridge (Auckland, New Zealand)

Dystonia  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Healthcare Resource Utilization (HCRU)

T. Xie, X. Ye, J. de Courcy, J. Mellor, J. Zamudio, L. Chiodo, Y. Bao (Mettawa, IL, USA)

Parkinsonisms and Parkinson-Plus  ·  Agora 3 West, Level 3
1:45pm-3:15pm
The Impact of the New Classification Criteria on the Incidence of Tremor Syndromes

A. Avila, N. Caballol, A. Planas-Ballvé, MI. Gómez-Ruiz, M. Balagué-Marmaña, X. Cardona (Barcelona, Spain)

Tremor  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
The Impact of Tourette Syndrome and Tic Disorders on Education, Occupational and Personal Life

I. Malaty, D. Shineman, W. Deeb (Gainesville, FL, USA)

Tics/Tourette  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 69
  • Next Page»

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley